Carregant...
The “return” of hepatitis B
There has been a significant advance in the treatment of chronic Hepatitis B virus (HBV) infection and the following drugs were approved for therapy: Conventional interferon (IFN), pegylated interferon alfa-2a (PEG IFN α2a), lamivudine, adefovir and entecavir. Compared to nucleoside analogues IFN in...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Baishideng Publishing Group Co., Limited
2006
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4087767/ https://ncbi.nlm.nih.gov/pubmed/17131468 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v12.i44.7081 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|